Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05252702 · ClinicalTrials.gov registry record · NA
Aveir DR i2i Study
A NA study of Bradycardia and Cardiac Pacemaker, Artificial, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 464
- Enrollment target
- 20
- Study locations
NCT05252702 is a NA study of Bradycardia and Cardiac Pacemaker, Artificial that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 464 participants, below the 4,397-participant average among 29 other Bradycardia trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT05252702, a NA study of Bradycardia and Cardiac Pacemaker, Artificial, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 464 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
Conditions Studied
Interventions
- DEVICE Aveir DR Leadless Pacemaker System
Study Locations (20)
California
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- USC University Hospital - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
- Premier Cardiology, Inc - Newport Beach
- Providence Medical Foundation - Orange
- Huntington Memorial Hospital - Pasadena
- University of California at San Diego (UCSD) Medical Center - San Diego
- Pacific Heart Institute - Santa Monica
Florida
- Baptist Medical Center - Jacksonville
- Naples Heart Rhythm Specialists, PA - Naples
- AdventHealth Orlando - Orlando
- Sarasota Memorial Hospital - Sarasota
Arkansas
- Arrhythmia Research Group - Jonesboro
- Arkansas Heart Hospital - Little Rock
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Hospital - Atlanta
Arizona
- HonorHealth - Scottsdale
Colorado
- South Denver Cardiology Associates PC - Littleton
District of Columbia
- Washington Hospital Center - Washington D.C.
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2025-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05252702
The ClinicalTrials.gov registry entry for NCT05252702 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 464 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,397-participant average among 29 other Bradycardia trials with a reported enrollment target (89% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Aveir DR Leadless Pacemaker System is the first listed.
NCT05252702 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Arkansas.
Frequently Asked Questions
What is clinical trial NCT05252702 about?
NCT05252702 is a clinical study titled "Aveir DR i2i Study". Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
What is the current status of trial NCT05252702?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 464 participants. The study started on 2022-02-02. Estimated completion is 2025-11.
What conditions does trial NCT05252702 study?
This clinical trial studies the following conditions: Bradycardia, Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder.
What interventions are being tested in trial NCT05252702?
The interventions under investigation include: Aveir DR Leadless Pacemaker System (DEVICE).
Who is sponsoring clinical trial NCT05252702?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05252702 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
ACTIVE NOT RECRUITING · NA
-
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
ACTIVE NOT RECRUITING · NA
-
EMRI SureScan™ Clinical Study
COMPLETED · NA
-
ECG Belt to Assess Electrical Synchronization
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.